Unity HA Awarded Breakthrough Device Designation for Implantable Neurostimulation Technology to Treat Cluster Headache Pain
/PRNewswire/ -- Unity HA announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the Pulsante® SPG...
Peter Bonutti Breakthrough Device Program Autonomic Technologies Inc Drug Administration Bonutti Research Inc Breakthrough Device Designation
Source: prnewswire.com